Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-09-16 Sale |
2024-09-18 9:53 pm |
ALIMERA SCIENCES INC | ALIM | Snisarenko John Director |
10,000 | $0 | $0 | 0 (Direct) |
View |
| 2020-08-10 Purchase |
2020-08-11 4:03 pm |
Oyster Point Pharma Inc. | OYST | Snisarenko John Chief Commercial Officer |
4,000 | $25.97 | $103,880 | 7,000 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-10-02 Option Award |
2023-10-04 4:42 pm |
N/A 2033-10-01 |
ALIMERA SCIENCES INC | ALIM | Snisarenko John Director |
50,000 | $0 | 50,000 (Direct) |
View |
| 2023-01-04 Option Award |
2023-01-06 5:19 pm |
N/A 2033-01-03 |
ALIMERA SCIENCES INC | ALIM | Snisarenko John Director |
6,000 | $0 | 6,000 (Direct) |
View |
| 2022-01-09 Option Award |
2022-01-11 7:47 pm |
N/A 2032-01-08 |
Oyster Point Pharma Inc. | OYST | Snisarenko John Chief Commercial Officer |
66,600 | $0 | 84,822 (Direct) |
View |
| 2021-11-02 Option Award |
2021-11-04 8:14 pm |
N/A 2031-11-01 |
ALIMERA SCIENCES INC | ALIM | Snisarenko John Director |
6,000 | $0 | 6,000 (Direct) |
View |
| 2021-09-22 Option Award |
2021-09-24 4:44 pm |
N/A 2031-09-21 |
Oyster Point Pharma Inc. | OYST | Snisarenko John Chief Commercial Officer |
20,000 | $0 | 20,000 (Direct) |
View |
| 2021-01-29 Option Award |
2021-02-02 6:35 pm |
N/A 2031-01-28 |
Oyster Point Pharma Inc. | OYST | Snisarenko John Chief Commercial Officer |
61,722 | $0 | 68,722 (Direct) |
View |
| 2020-06-18 Option Award |
2020-06-22 4:23 pm |
N/A 2030-06-17 |
ALIMERA SCIENCES INC | ALIM | Snisarenko John Director |
3,333 | $0 | 3,333 (Direct) |
View |